Showing results (621-630 of 666) with videos related to
Sort By:
Pageof 67
Diabetes Research and Clinical Practice|September 1, 1996
Dominant TCR alpha-chain clonotypes and interferon-gamma are expressed in the pancreas of patients with recent-onset insulin-dependent diabetes mellitusK Yamagata, H Nakajima, K Tomita, et al.Clinical and Experimental Medicine|March 8, 2003
Effects of cilostazol on serum lipid concentrations and plasma fatty acid composition in type 2 diabetic patients with peripheral vascular diseaseN Nakamura, T Hamazaki, H Johkaji, et al.Nano Letters|September 8, 2020
Topological Kagome Magnet Co3Sn2S2 Thin Flakes with High Electron Mobility and Large Anomalous Hall EffectM Tanaka, Y Fujishiro, M Mogi, et al.Biochemical and Biophysical Research Communications|April 2, 2002
Increased plasma HB-EGF associated with obesity and coronary artery diseaseSatoru Matsumoto, Ken Kishida, Iichiro Shimomura, et al.Neuroimage|April 4, 2024
Brain structures and functional connectivity in neglected children with no other types of maltreatmentNatasha Y S Kawata, Shota Nishitani, Akiko Yao, et al.The British Journal of Ophthalmology|October 30, 2007
The metabolic syndrome and retinal microvascular signs in a Japanese population: the Funagata studyR Kawasaki, J M Tielsch, J J Wang, et al.International Journal of Molecular Sciences|February 26, 2025
An Osteoblast-Specific Enhancer and Subenhancer Cooperatively Regulate Runx2 Expression in ChondrocytesYuki Matsuo, Xin Qin, Takeshi Moriishi, et al.Annals of Internal Medicine|July 21, 1998
Relation of interferon therapy and hepatocellular carcinoma in patients with chronic hepatitis C. Osaka Hepatocellular Carcinoma Prevention Study GroupY Imai, S Kawata, S Tamura, et al.Liver|August 26, 2000
Long-term responders without eradication of hepatitis C virus after interferon therapy: characterization of clinical profiles and incidence of hepatocellular carcinomaI Yabuuchi, Y Imai, S Kawata, et al.Internal Medicine (Tokyo, Japan)|February 24, 2001
Duodenal somatostatinoma and erythrocytosis in a patient with von Hippel-Lindau disease type 2AY Karasawa, M Sakaguchi, S Minami, et al.Pageof 67